Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection - Wikidata - wikimedia - TriplyDB

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection

http://www.wikidata.org/entity/Q27485184

about

The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interface Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus.Viral calciomics: interplays between Ca2+ and virus WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infection Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships Mucosal transmission of human immunodeficiency virus Anx2 interacts with HIV-1 Gag at phosphatidylinositol (4,5) bisphosphate-containing lipid rafts and increases viral production in 293T cells Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression.Human antimicrobial peptides and proteins Profiling of cellular proteins in porcine reproductive and respiratory syndrome virus virions by proteomics analysis.Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation.Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity A comparative proteomic analysis of the soluble immune factor environment of rectal and oral mucosa.The mouth: a gateway or a trap for HIV?Proteomic analysis of primary duck hepatocytes infected with duck hepatitis B virus Innate immunity against HIV: a priority target for HIV prevention research Trappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:C HIV acquisition is associated with increased antimicrobial peptides and reduced HIV neutralizing IgA in the foreskin prepuce of uncircumcised men.Aberrant host defense against Leishmania major in the absence of SLPI.A link between interferon and augmented plasmin generation in exocrine gland damage in Sjögren's syndrome.Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.Identification of a mutated BHK-21 cell line that became less susceptible to Japanese encephalitis virus infection.Identification of annexin II as a novel secretory biomarker for breast cancer.Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids Systemic and mucosal differences in HIV burden, immune, and therapeutic responses Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity.Female genital tract secretions inhibit herpes simplex virus infection: correlation with soluble mucosal immune mediators and impact of hormonal contraception.Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infection.Vaginal innate immune mediators are modulated by a water extract of Houttuynia cordata Thunb Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing.Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression.Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells Tonsil epithelial factors may influence oropharyngeal human immunodeficiency virus transmission.Macroautophagy Regulation during HIV-1 Infection of CD4+ T Cells and Macrophages.

P2860

Q21134079-C0D4E655-8EE8-4A8E-8D32-3E0ABD07E32F Q21143809-6EA1CD56-C32F-4B10-AE64-0F48386C43B8 Q21245044-9ED02003-924F-4223-AFA7-848DCB6E25F0 Q24533383-28BC3709-4C5D-44CC-9017-1095F239270C Q24597190-615DF419-AFE1-4C3C-9CD7-FDAFB8026EB8 Q24657262-317873EF-66DB-47A6-89E5-D6DA571F64CC Q24677778-81B6FF1B-5571-489D-A9CB-82E89A6D25D0 Q28297791-57252C2C-50FC-44E9-8B8D-F83194CC4457 Q28731648-B8C2CEE0-F4C7-4FFF-9E36-E881653ABC9A Q30412036-0295FEDF-3138-4058-95BF-13EBD3C2011C Q33422993-6E74AAF3-9FD2-42FE-8662-92E0315C0DEB Q33604135-A73AB48B-DB89-411B-8D93-0511E5990D30 Q33673156-2A53E322-6FA8-4D2E-8727-7A68F5E99BE5 Q33695004-A3A5C6F7-B3AA-4D6D-BA3B-967EEF6131C2 Q33707301-33F81F6D-EED9-4174-90CE-EBAD913FE095 Q33780434-499BE436-C995-49CC-A49D-88F35359FD7F Q33825756-5C1FD0C8-87B8-46C8-9890-00710CF1FC14 Q33874252-4CABE567-A931-477A-A9D1-0AF28B391C80 Q33997952-92CB7944-4182-4552-80CC-24812DE41A44 Q34243462-51025EDC-B90A-4B98-8296-8D9690759B23 Q34251265-AF6910CC-1F32-48FB-867E-2F036ACFD6BE Q34282935-E041FF62-2B49-467A-8DCA-14BF88B4995E Q34341332-5C012FA0-2FFA-4691-ACCE-933E5D8D7547 Q34655650-80C5B9DE-0BDE-4627-A054-D022ECD84437 Q34680240-B978CB07-3CEF-41ED-9292-0685BAF2B09D Q34722619-7C3E2A66-B3D9-4187-9C94-93515A132246 Q34982525-DB5F577B-39B3-43C4-85E0-CA673524E7BA Q35071264-76689079-EF19-45EB-9C23-FF18E59782E4 Q35073965-83EC42B5-54B1-4805-B5FD-C64FAF4C9A45 Q35075174-AF6E2D4C-04F5-449B-84CD-5378E38D65A9 Q35190200-FB2AD29A-6F64-463F-9D38-16A39749F0F7 Q35531212-8768EF1F-D57F-4AF9-904B-D05A2AB5B678 Q35565782-A0D15219-E8A8-400F-A8E5-D745019E50B6 Q35662068-7053B6D2-860E-4986-B5A2-FD00FEC21E9A Q35664514-878E9C4F-3D51-406E-A995-2FE8A25E2871 Q35779604-1F983D24-DE69-43B7-A765-35EAC27477CC Q35850696-8F37FD4F-570E-4D9A-AF11-89BDB6896248 Q35868058-BE3F4076-AA28-484B-BF99-E19F8FAD8F21 Q35916009-FCDBDDCE-9CDE-4C38-A3A6-7383892EBE28 Q35939279-3630FB82-C2BC-465A-A802-6BEE724EDC3B

P2860

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection

http://www.wikidata.org/entity/Q27485184

description

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

article scientifique (publié 2004/11/15)

@fr

articolo scientifico (pubblicato il 2004/11/15)

@it

artigo científico (publicado na 2004/11/15)

@pt

artículu científicu espublizáu en 2004

@ast

im November 2004 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: 15 November 2004)

@en

vedecký článok (publikovaný 2004/11/15)

@sk

vetenskaplig artikel (publicerad på 2004/11/15)

@sv

name

Secretory Leukocyte Protease I ...... for Macrophage HIV-1 Infection

@ast

Secretory Leukocyte Protease I ...... for Macrophage HIV-1 Infection

@en

Secretory Leukocyte Protease I ...... for Macrophage HIV-1 Infection

@nl

type

label

Secretory Leukocyte Protease I ...... for Macrophage HIV-1 Infection

@ast

Secretory Leukocyte Protease I ...... for Macrophage HIV-1 Infection

@en

Secretory Leukocyte Protease I ...... for Macrophage HIV-1 Infection

@nl

prefLabel

Secretory Leukocyte Protease I ...... for Macrophage HIV-1 Infection

@ast

Secretory Leukocyte Protease I ...... for Macrophage HIV-1 Infection

@en

Secretory Leukocyte Protease I ...... for Macrophage HIV-1 Infection

@nl

P1433

Q27485184-6A1D5BB9-4115-4350-A332-ABE8F7C3DC9B

P1476

Q27485184-98947513-9CEA-4B28-B745-72D15ACEEBDC

P2093

Q27485184-3B98A561-3A61-4DBF-BDE7-E72D8DD52783

Q27485184-6B79524D-469C-41A6-8F3A-28BD2E1A4375

Q27485184-7DDB8F0F-34A8-4367-9A49-CF236B110205

Q27485184-904F9999-8711-46B8-B0FD-EE964DA6D682

Q27485184-9B2ACF50-845E-4751-A601-E0EA2D950AB6

Q27485184-A65C733D-A757-420D-8755-49A9569A1DD8

Q27485184-E07BD42C-97D0-4CE5-87FD-B27039A6ABC5

Q27485184-ECF4B8DE-F924-47A7-8F0F-9C5FBB901862

P2860

Q27485184-0923338B-A034-40D3-B500-05952FB6C4CE

Q27485184-11295309-1967-4234-9DC2-25ABADC39E50

Q27485184-151FDCD0-B9B4-4303-8CFC-CCF88F0CA3B0

Q27485184-15677E62-F769-4E39-82F5-C574207514A1

Q27485184-1EB3F9EF-6ECD-46DE-9EAC-93C51B88F0EF

Q27485184-21423B9C-8FE0-4C83-8298-59681EBDA3B6

Q27485184-26BD2E03-DCB6-472D-8D26-74D05CDCE822

Q27485184-28EF9735-3453-47D3-B789-1EA85D3AFB82

Q27485184-34264325-04A4-439B-A41F-3DE9609A8B22

Q27485184-453F659D-CF45-49DD-A718-B9A6E5335DB3

P304

Q27485184-2F96E484-5E19-4BAF-A4A6-571D88F90D4D

P31

Q27485184-D2E43088-97DF-4D34-B0AC-22EE069B085E

P356

Q27485184-130928C5-551B-43C3-9C05-65C044269816

P407

Q27485184-A006CEEE-07B3-4E21-9D30-72237D34E862

P433

Q27485184-8EEEF600-07A6-4156-8577-AAE1F52DB82B

P478

Q27485184-ED7E8F4D-0D01-42CD-BA6D-A975AE3A28CD

P577

Q27485184-7C53BA6A-4933-4AD5-8DD6-A9AE5C00567D

P5875

Q27485184-7F84653E-FD12-4FE7-8E69-24499E195539

P698

Q27485184-D63CAB77-2D56-4609-BFAA-701E46AE6E67

P921

Q27485184-64B499FE-019D-43A9-9A22-339A3DC018AD

Q27485184-8B9B1008-2521-4408-8778-83FF1E8E2D7A

P932

Q27485184-98A9E98F-D905-4ED8-8EB8-305BAFA91E3A

P356

P1433

Journal of Experimental Medicine

P1476

Secretory Leukocyte Protease I ...... for Macrophage HIV-1 Infection

@en

P2093

Carl T Wild

http://www.w3.org/2001/XMLSchema#string

Ge Ma

http://www.w3.org/2001/XMLSchema#string

Jennifer Swisher

http://www.w3.org/2001/XMLSchema#string

Kejian Lei

http://www.w3.org/2001/XMLSchema#string

Neil Hardegen

http://www.w3.org/2001/XMLSchema#string

Sharon M Wahl

http://www.w3.org/2001/XMLSchema#string

Teresa Greenwell-Wild

http://www.w3.org/2001/XMLSchema#string

Wenwen Jin

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase

The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release

Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2

Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression

HIV entry and its inhibition

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis

Annexins: from structure to function

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

P304

1337-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20041115

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

200

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8182371

http://www.w3.org/2001/XMLSchema#string

P698

15545357

http://www.w3.org/2001/XMLSchema#string

P921

P932

2211913

http://www.w3.org/2001/XMLSchema#string